🔎 Trials Near Me

Nyumbani › Unenepu › Texas

Majaribio ya kliniki ya Unenepu katika jimbo la Texas

Masomo 81 ya Unenepu yanatafuta washiriki katika vituo vya jimbo la Texas.

Miji katika jimbo la Texas

Maandishi rasmi ya utafiti (Kiingereza)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Amarillo Medical Specialists /ID# 282380, Amarillo
  • Elligo Clinical Research Center /ID# 282166, Austin
  • JCCT - Juno Bellaire /ID# 282263, Bellaire
  • na zaidi ya 4
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07752979

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

  • Kailera Clinical Site, San Antonio
InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07793929

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Horizon Clinical Research Group, Cypress
  • Cardiovascular Specialists of Willowbrook, Houston
  • Texas Cardiology Associates of Houston, Kingwood
  • na zaidi ya 2
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07783802

Spinal Cord Injury Model Systems (SCIMS) - Education Module

  • Baylor Scott & White Institute for Research, Dallas
Inaajiri
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06003686

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • UT Southwestern Med Center, Dallas
  • PlanIt Research, PLLC, Houston
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • DM Clinical, Houston
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • na zaidi ya 3
InaajiriHatua 3
Umri 8 hadi 18 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Amarillo Medical Specialists, Amarillo
  • North Texas Endocrine Center, Dallas
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07720271

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

  • Endeavor Clinical Trials, San Antonio
InaajiriHatua 1
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Amarillo Med Spec LLP, Amarillo
  • Texas Diabetes & Endocrinology, Austin
  • Pinnacle Clinical Research, Brownsville
  • na zaidi ya 7
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
  • VIP Trials, San Antonio
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Dell Children's Medical Center - PIN, Austin
  • Driscoll Children's Hospital, Corpus Christi
  • McGovern Medical School, Houston
  • na zaidi ya 4
InaajiriHatua 3
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • Amarillo Medical Specialists, Amarillo
  • Velocity Clinical Res-Dallas, Dallas
  • Care United Research, LLC, Forney
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • IMA Clinical Research Austin, Austin
  • Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
  • Velocity Clinical Research, Dallas, Dallas
  • na zaidi ya 5
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • UT Southwestern Medical Center, Dallas
  • Juno Research, Houston
  • Activian Clinical Research, Kingwood
  • na zaidi ya 7
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, DeSoto
  • Research Site, El Paso
  • Research Site, Houston
  • na zaidi ya 5
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • FutureSearch Trials of Neurology, Austin
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • PharmaTex Research, LLC, Amarillo
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
  • na zaidi ya 22
InaajiriHatua 3
Umri 45 hadi 99 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • The University of Texas Health Science Center at Houston, Bellaire
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
  • na zaidi ya 1
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • JCCT - Juno Bellaire Site, Bellaire
  • Epic Medical Research - DeSoto, DeSoto
  • Valley Institute of Research - Fort Worth, Fort Worth
  • na zaidi ya 5
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • IMA Clinical Research Austin, Austin
  • FutureSearch Trials of Dallas, Dallas
  • PlanIt Research, PLLC, Houston
  • na zaidi ya 2
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

  • The University of Texas at Austin, Austin
  • The University of Texas Health Science Center at Houston, Houston
InaajiriHatua 2Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Austin
  • AURORA-1 Clinical Site, Brownsville
  • AURORA-1 Clinical Site, DeSoto
  • na zaidi ya 8
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Austin
  • AURORA-2 Clinical Site, Brownsville
  • AURORA-2 Clinical Site, DeSoto
  • na zaidi ya 10
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • PharmaTex Research, LLC, Amarillo
  • Austin Heart, Austin
  • Javara Research, Conroe
  • na zaidi ya 13
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Headlands Research Brownsville, Brownsville
  • Velocity Clinical Research, Dallas
  • South Texas Research Institute - Edinburg, Edinburg
  • na zaidi ya 5
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Juno Research, Houston
  • Southern Endocrinology Associates, Mesquite
  • Texas Diabetes & Endocrinology, P.A., Round Rock
  • na zaidi ya 2
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Bellaire Clinical Research, LLC, Bellaire
  • South Texas Research Institute - Brownsville, Brownsville
  • South Texas Clinical Research, Corpus Christi
  • na zaidi ya 8
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351045

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Webster
InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
Umri 25 hadi 75 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07815678

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • Epic Medical Research, DeSoto
  • Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
  • Biorhythms Center for Integrative Sleep Medicine, El Paso
  • na zaidi ya 3
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Austin
  • ACCOMPLISH-2 Research Site, Farmers Branch
  • ACCOMPLISH-2 Research Site, Houston
  • na zaidi ya 4
InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • Cedar Health Research, Dallas
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07770841

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • Epic Medical Research, DeSoto
  • Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
  • Biorhythms Center for Integrative Sleep Medicine, El Paso
  • na zaidi ya 3
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • IMA Clinical Research Austin, Austin
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
  • na zaidi ya 3
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
  • Biopharma Informatic, LLC, Houston
  • na zaidi ya 5
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07215559

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

  • ICON, San Antonio
InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 55 · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT07767175

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  • Bellaire Dermatology Associates, Bellaire
  • Modern Research Associates, PLLC, Dallas
  • Center for Clinical Studies, Houston
  • na zaidi ya 3
InaajiriHatua 4
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Amarillo
  • Kailera Clinical Site, Brownsville
  • Kailera Clinical Site, DeSoto
  • na zaidi ya 5
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284901

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.